Cas 1214206-63-9,4-(9H-pyrido[2,3-b]indol-6-yl)-4-((4-methylpiperazine-1-yl)methyl)benzamide

1214206-63-9

Post Buying Request

Basic information

Product Name: 4-(9H-pyrido[2,3-b]indol-6-yl)-4-((4-methylpiperazine-1-yl)methyl)benzamide
Synonyms: 4-(9H-pyrido[2,3-b]indol-6-yl)-4-((4-methylpiperazine-1-yl)methyl)benzamide
CAS NO:1214206-63-9
Molecular Formula:
Molecular Weight: 482.609
EINECS: N/A
Product Categories: N/A
Mol File: 1214206-63-9.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(9H-pyrido[2,3-b]indol-6-yl)-4-((4-methylpiperazine-1-yl)methyl)benzamide(CAS DataBase Reference)
NIST Chemistry Reference: 4-(9H-pyrido[2,3-b]indol-6-yl)-4-((4-methylpiperazine-1-yl)methyl)benzamide(1214206-63-9)
EPA Substance Registry System: 4-(9H-pyrido[2,3-b]indol-6-yl)-4-((4-methylpiperazine-1-yl)methyl)benzamide(1214206-63-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1214206-63-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1214206-63-9 Suppliers

Recommended suppliersmore

1214206-63-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1214206-63-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,4,2,0 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1214206-63:
(9*1)+(8*2)+(7*1)+(6*4)+(5*2)+(4*0)+(3*6)+(2*6)+(1*3)=99
99 % 10 = 9
So 1214206-63-9 is a valid CAS Registry Number.

1214206-63-9Upstream product

1214206-63-9Downstream Products

1214206-63-9Relevant articles and documents

Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl

-

Page/Page column 49, (2010/04/24)

The present invention relates to compounds of formula (I) wherein R1, R2 and R3 are as defined in the description, to their pharmaceutical compositions and use thereof for the treatment of cancer expressing oncogenic ALK protein, particularly anaplastic l

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1214206-63-9